Suchergebnisse - "de Leeuw, David C"

PubPharm (28)

1

Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia

enthalten in: Leukemia | 2024

von Tettero, J. | Heidinga, M. | Mocking, T. | +11

2

Prognostic Significance of Measurable Residual Disease Detection by Flow Cytometry in Autologous Stem Cell Apheresis Products in AML

enthalten in: HemaSphere | 2023

von Tettero, J. | Buisman, Y. | Ngai, L. | +10

3

ATG versus PTCy in matched unrelated donor haematopoietic stem cell transplantations with non-myeloablative conditioning

enthalten in: British journal of haematology | 2023

von Aydin, M. | de Leeuw, D. | Rutten, C. | +9

4

Prospective validation of the prognostic relevance of CD34+CD38- AML stem cell frequency in the HOVON-SAKK132 trial

enthalten in: Blood | 2023

von Ngai, L. | Hanekamp, D. | Janssen, F. | +27

5

Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients

enthalten in: Pharmaceutics | 2023

von Huntjens, D. | Dijkstra, J. | Verwiel, L. | +9

6

Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment

enthalten in: Current oncology reports | 2022

von de Leeuw, D. | Ossenkoppele, G. | Janssen, J.

7

Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia

enthalten in: Clinical drug investigation | 2022

von Schutte, T. | Stege, C. | Smits, M. | +3

8

Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia

enthalten in: Clinical drug investigation | 2022

von Schutte, T. | Stege, C. | Smits, M. | +3

9

Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia

enthalten in: Clinical drug investigation | 2022

von Schutte, T. | Stege, C. | Smits, M. | +3

10

Midostaurin as the Most Likely Cause of Bilateral Adrenal Masses in a Patient with Acute Myeloid Leukemia

enthalten in: Clinical drug investigation | 2022

von Schutte, T. | Stege, C. | Smits, M. | +3